Introduction
============

The menopause marks a major biological transition in the lives of all women with potentially deep psychological and socioeconomic changes ([@b3-cia-3-561]). Attitudinal aspects of the menopause transition have been studied for several decades starting with studies by [@b12-cia-3-561]. However, most studies of mid-life and menopause attitudes have systematically excluded women with serious illness, disability, or substance abuse.

As the human immunodeficiency virus (HIV) epidemic enters its third decade, a high percentage of women with HIV will also be entering menopause, their lives extended by improvements in antiretroviral therapies, ie, Highly Active Anti-Retroviral Therapy (HAART) ([@b14-cia-3-561]). Examination of the literature provides little insight into how women with HIV/acquired immunodeficiency syndrome (AIDS) or who use street drugs for long periods may experience the menopause transition.

We assessed attitudes towards menopause in an impoverished, urban population of midlife women with and at-risk for HIV infection. We hypothesized that HIV and street drug use would be associated with a less positive attitude toward menopause than for the HIV-uninfected women in our study who did not use drugs. We felt it equally plausible that menopause was just one more, relatively minor stressor among the many difficult circumstances among women with HIV as has been suggested by a number of investigators regarding HIV itself ([@b13-cia-3-561]; [@b21-cia-3-561]).

Methods
=======

Sample
------

As previously described ([@b19-cia-3-561]), a total of 620 women participated in the "Natural History of Menopause in HIV-Infected Women" (Ms Study). Overall enrollment was guided to produce a study with balanced numbers of HIV-infected and uninfected women and with half of the women in the HIV-infected and uninfected groups having a history of heroin or cocaine use in the past five years. This study utilizes data gathered during the enrollment phase with ascertainment of menopause status with 12 months of amenorrhea postbaseline for those in the menopausal transition at time of interview.

Definition of menopause, perimenopause, and menopausal symptoms
---------------------------------------------------------------

Natural menopause was defined according to the [@b24-cia-3-561] as at least 12 consecutive months of amenorrhea not due to surgery or other obvious cause, such as extreme weight loss. Perimenopause was defined as absence of menses in at least 3 cycles but no more than 11 during the past 12 months. For this analysis we did not distinguish between early and late perimenopause due to small numbers of women in the perimenopause. Menopausal symptoms were classified into six groups, vasomotor, genitourinary, musculoskeletal, weight gain, palpitations, and insomnia and excluded psychological symptoms which were ubiquitous in the population ([@b10-cia-3-561]).

Dependent variable
------------------

A modified version of the Neugarten Attitudes Toward Menopause (ATM), a 35-item questionnaire, was administered as part of the baseline Ms interview. For each item on the ATM, women were asked to indicate if they agreed strongly, agreed somewhat, disagreed somewhat, or disagreed strongly or could not agree or disagree (don't know). Since the original Neugarten ATM was not designed for populations such as ours, a panel of 17 women familiar with the study population (primarily experienced research interviewers) selected a subset of ATM items. A 65% agreement was required by the panel in order to include an item. The items intended for middle-class, married women in the 1960s were dropped as inappropriate to a sample with an extensive history of street drug use and who are largely without partners. For example, we dropped: "After menopause, a woman gets more interested in activities outside the home." In the end we used 27 items (15 negative items, and 12 positive items) taken from the original ATM. Negative items were reverse coded for summation with positive items. Using this modified questionnaire, we condensed scores to a simple agree, don't know, or disagree code similar to scoring used for attitude items in the Study of Women Across the Nation (SWAN) ([@b20-cia-3-561]). We examined variables in relation to average score and also to scores above 2, indicating more positive attitude, compared to those 2 and lower

Exclusions
----------

Of the 620 women originally enrolled in Ms, women who had a hysterectomy and/or bi-lateral oophorectomy prior to entering the perimenopause (n = 22) were excluded. In addition, 24 women taking hormones for the symptoms of menopause during perimenopause within 6 months of interview were also excluded due to an inability to properly classify their status. Fifty-six women responding "don't know" more than 25% of the time on the ATM were dropped from analysis. Based on responses to questions on menopause symptoms, we found high nonresponse on the attitudes portion of the study instrument was likely to indicate lack of interest rather than simple lack of knowledge. A further 16 participants were excluded for incomplete or missing data. After the above exclusions, 502 women comprised the sample for this analysis.

Statistical methods
-------------------

Bivariate analysis of baseline characteristics was performed using chi-square, Fishers' exact test, ANOVA, Spearman correlation, or Wilcoxon rank tests as appropriate. Multiple logistic regression models were used to identify factors independently associated with an average score above 2 compared with 2 or lower. Variables examined included age and age^2^, race/ethnicity, education, marital status, HIV status, CD4 + cell count, HAART treatment, drug and alcohol use, menopause status, menopause symptoms, parity, body mass index (BMI), negative life events, and depressive symptoms. Women were classed as having depressive symptoms if Center for Epidemiologic Studies Short Depression Scale (CES-D) scores ≥23 as we have done in previous studies ([@b11-cia-3-561]; [@b19-cia-3-561]). Data were analyzed using Stata 9.0 (College Station, TX).

Results
=======

Among the 502 women, 260 (51.8%) were HIV-seropositive, and 92 women (18.3%) were postmenopausal. For HIV-positive, median CD4 count was 455.5 cells/m^3^ with an interquartile range (IQR) of 274--682. Sixty-four percent (168/261) were maintained on HAART at that time. The median age at interview was 43 (IQR: 40--46) with 27.3% reported using heroin and/or cocaine at the time of interview. The sample included 48.6% African American, 40.2% Hispanic, 9% non-Hispanic white, and 2.2% "other", which included mixed race.

The overall average attitude toward menopause score (scores from 1 most negative to 3 most positive) was 1.93 with IQR of 1.77--2.10. Among 502 women, 37.5% (188/502) had an average score \>2 showing a relatively favorable attitude toward menopause. We found no differences in attitude toward menopause by HIV infection status: 37.3% of the 260 HIV-seropositive women and 37.6% of the 242 seronegative women had scores indicating a positive attitude toward menopause. There were no associations between CD4 count or use of HAART with menopause attitude among those with HIV. African American women showed the most positive attitudes toward menopause compared with all other race or ethnic groups ([Table 1](#t1-cia-3-561){ref-type="table"}). Women reporting a current domestic partner (married or common-law) were less likely to have a positive attitude toward menopause than those with no partner (32.1% vs. 41.3%, p = 0.035).

Reproductive and medical history
--------------------------------

Menopause symptoms, but not menopause status, showed an inverse relationship with menopause attitude when women had more than 3 symptoms of any kind (p = 0.002) as shown in [Table 1](#t1-cia-3-561){ref-type="table"}. Single menopause symptoms, such as hot flashes, were not associated with attitude score.

Depressive symptoms and negative life events
--------------------------------------------

Depressive symptoms based on the CESD were related to a more negative menopause attitude score (p = 0.037). High rates of traumatic events were found among our participants: 42% abused as children and 36.1% molested as children, 45.8% raped and 59.4% assaulted as adults. In addition, 26.7% witnessed murder and 19.6% suffered a child's death. Witness to murder and death of a child showed a statistically significant difference in menopause attitude ([Table 1](#t1-cia-3-561){ref-type="table"}).

Drug and alcohol use
--------------------

For women reporting current use of heroin and/or cocaine in any form or route within 6 months of baseline interview, a somewhat more positive view of menopause was shown compared with nonusers (43.8% vs. 35.1%, p = 0.072). There was a similar result for problem drinking based on the CAGE screening instrument. Enrollment in methadone and cigarette smoking were not associated with attitudes toward menopause.

Multivariate results
--------------------

African Americans showed 72% greater odds of a positive attitude (OR~adj~ = 1.72, 95% CI 1.16--2.57) than all other race or ethnic groups while adjusting for the other variables in this model ([Table 2](#t2-cia-3-561){ref-type="table"}). Experience of \>3 menopausal symptoms and negative life events---being a witness to a murder, and the death of a child---were significantly associated with negative attitudes towards menopause (OR = 0.62, 95% CI 0.42--0.93 and OR = 0.64, 95% CI 0.43--0.93, respectively). Depressive symptoms, street drug use, and having a domestic partner, which was significant in single variable analyses, did not remain independent predictors in multivariate results. HIV status, menopause status, and age at interview were not associated with menopause attitudes. Age, age^2^, and menopause status were examined in all models but dropped in the final model due to consistent lack of association.

Discussion
==========

The most prominent finding in our study is the overall low level of women expressing a positive attitude (37.5% positive, with 1.93 overall mean score) toward menopause in this impoverished population with a high prevalence of HIV. In contrast, the SWAN study ([@b20-cia-3-561]) enrolled an ethnically diverse population and reported an overall mean "on the positive side of neutral." A comparable result in our population would be an overall average above 2.00; in fact, it was infrequent to observe average scores above two on most subcategories of variables examined in our study as shown in [Table 1](#t1-cia-3-561){ref-type="table"}. Similar to SWAN, [@b22-cia-3-561] showed an overall nonnegative, largely neutral attitude toward menopause in a small, random and diverse sample of women. Since these studies do not use identical menopause attitude items, we do not compare actual overall mean results.

Our study population differs from others as it has the lowest educational levels (43% not completing high school), severe stressors including homelessness, street drug use and addiction, and adverse life events such as witness to murder, sexual abuse and rape. These factors probably colored overall attitudes toward their lives in general.

Menopause status and symptoms
-----------------------------

Contrary to studies showing postmenopausal status associated with positive attitudes toward menopause ([@b12-cia-3-561]; [@b22-cia-3-561]; [@b20-cia-3-561]), our postmenopausal women did not demonstrate more positive attitudes than peri- or premenopausal women. However, having more than 3 symptoms of menopause was associated with more negative menopause attitude in our data, suggesting that symptoms may outweigh menopause status. The SWAN study found physical symptoms associated with attitudes, however these symptoms were not independent of menopause status in multivariate models. The role of symptoms in menopause can be complex in our population. Many of our study participants experience a wide range of conditions such as tuberculosis, HIV-related symptoms, and drug withdrawal that can overlap or closely resemble some symptoms of menopause. In our investigation of this issue, we found that women did not mis-attribute menopause symptoms to other conditions so much as they simply did not associate them with menopause ([@b7-cia-3-561]). For example, 70% attributed hot flashes to menopause and 29% attributed vaginal dryness to menopause. Our study population also differs from others in its high prevalence of early menopause at a median age of 47 ([@b19-cia-3-561]). The observed early menopause is supported in a subsample of the same Ms cohort members in which menopause symptoms are shown at younger ages than the general population ([@b10-cia-3-561]). Furthermore, analysis of reproductive hormone patterns in this population has shown that they are consistent with menopause status and support an earlier menopause onset ([@b18-cia-3-561]). This study also confirmed that age and WHO menopause status classifications used in our study were significantly related to follicle stimulating hormone levels.

Demographic results
-------------------

Consistent with other reports ([@b15-cia-3-561]; [@b20-cia-3-561]), African American women had the most positive attitudes toward menopause: 44.3% positive compared with Hispanic women with 29.7% having a positive attitude. The literature shows less consistency for associations with educational attainment ([@b9-cia-3-561]), although the SWAN found higher education to be related to better attitude after controlling on age, menopause status, and other variables. With over 43% of women not completing high school and the fairly uniform low socioeconomic status of our participants, we found no such association.

Having a domestic partner---especially a supportive partner---has been reported as a factor in a positive attitude towards menopause ([@b1-cia-3-561]). A supportive network has similarly been shown to relate to a positive attitude toward the menopausal transition ([@b17-cia-3-561]). Whether married or common-law, having a domestic partner was related to less favorable attitudes toward menopause in our data but only in bivariate analyses.

Stressful life events, depressive symptoms, and HIV infection status
--------------------------------------------------------------------

In our previous study ([@b10-cia-3-561]) we found that menopause symptoms were associated with depressive symptoms and negative life events; however, we did not find depressive symptoms independently associated with menopause attitudes. Instead, in this study menopause symptoms and negative life events were related to attitude. The literature shows conflicting results on this issue with some reporting increases in depressive symptoms during the menopausal transition ([@b8-cia-3-561]; [@b5-cia-3-561]; [@b6-cia-3-561]), while others do not ([@b23-cia-3-561]; [@b16-cia-3-561]; [@b2-cia-3-561]).

We found that HIV infection status per se was not associated with menopause attitudes. In other studies, the psychological profile of impoverished women with HIV is more likely shaped by the milieu of poverty or drug problems than by HIV alone ([@b13-cia-3-561]; [@b21-cia-3-561]). This appears to be the case for menopause as well.

Conclusions
===========

For HIV-infected and drug-using women, the menopause transition is likely to be a very different experience than for women living in mainstream culture. Menopause is an important life event that can mark a change into a period of increasing health risk from cardiovascular disease, osteoporosis, and early death. It is notable that these women who once thought they would die of HIV in a short period are now facing menopause amidst the burdens of poverty, multiple high stress events, and age-related chronic disease conditions.
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###### 

Single variable associations with attitudes toward menopause score[\*](#tfn1-cia-3-561){ref-type="table-fn"} in (N = 502) women enrolled in Menopause Study (Ms)

                                         n (%)        Mean score   \% Positive attitude   p-value[\*](#tfn1-cia-3-561){ref-type="table-fn"}
  -------------------------------------- ------------ ------------ ---------------------- ---------------------------------------------------
  Age at baseline                                                                         0.757
   35--44                                253 (50.4)   1.93         39.1                   
   45--49                                179 (35.7)   1.89         34.6                   
   50--54                                49 (9.8)     1.98         36.7                   
   55+                                   21 (4.2)     2.00         42.9                   
  Race/Ethnicity                                                                          0.002
   African American                      244 (48.6)   1.97         44.3                   
   Hispanic                              202 (40.2)   1.89         29.7                   
   White                                 45 (9.0)     1.91         37.8                   
   Other                                 11 (2.2)     1.83         27.3                   
  Education (years)                                                                       0.498
   ≤11                                   218 (43.4)   1.90         35.8                   
   12+                                   284 (56.6)   1.94         38.7                   
  Marital status                                                                          0.035
   Has partner                           209 (41.6)   1.89         32.1                   
   No partner                            293 (58.4)   1.95         41.3                   
  Menopause status                                                                        0.912
   Menopause                             92 (18.3)    1.94         39.1                   
   Perimenopause                         162 (32.3)   1.93         36.4                   
   Premenopause                          248 (49.4)   1.91         37.5                   
  Menopause symptoms at baseline                                                          0.002
   0--3 symptoms                         311 (62.0)   1.95         42.8                   0.332
   \>3 symptoms                          191 (38.0)   1.89         28.8                   
  Parity (number of livebirths)                                                           
   None                                  59 (11.8)    1.92         39.0                   
    1--2                                 201 (40.0)   1.96         41.8                   
    3--4                                 170 (33.9)   1.90         34.1                   
    5+                                   72 (14.3)    1.90         31.9                   
  Body mass index (BMI)                                                                   0.604
   \<18.5 (underweight)                  7 (1.4)      2.01         57.1                   
   18.5--24.9 (normal)                   126 (25.1)   1.93         38.9                   
   25--29.9 (overweight)                 144 (28.7)   1.94         38.9                   
   ≥3 (obese)                            224 (44.7)   1.91         35.3                   
  HIV infection status                                                                    0.945
   HIV-positive                          260 (51.8)   1.93         37.3                   
   HIV-negative                          242 (48.2)   1.92         37.6                   
  CESD Score                                                                              0.037
   ≥23                                   195 (38.8)   1.88         31.8                   
   \<23                                  307 (61.2)   1.96         41.0                   
  Witness to murder                                                                       0.034
   Yes                                   134 (26.7)   1.88         30.0                   
   No                                    368 (73.3)   1.94         40.2                   
  Abused as child                                                                         0.092
   Yes                                   211 (42.0)   1.90         33.2                   
   No                                    291 (58.0)   1.96         40.6                   
  Molested as child                                                                       0.671
   Yes                                   181 (36.1)   1.92         38.7                   
   No                                    321 (63.9)   1.93         36.8                   
  Raped as adult                                                                          0.730
   Yes                                   230 (45.8)   1.92         38.3                   
   No                                    272 (54.2)   1.93         36.8                   
  Attacked as adult                                                                       0.940
   Yes                                   298 (59.4)   1.93         37.6                   
   No                                    204 (40.6)   1.92         37.3                   
  Death of a child                                                                        0.035
   Yes                                   105 (20.9)   1.88         28.6                   
   No                                    397 (79.1)   1.94         39.8                   
  Current drug user (cocaine/heroin)                                                      0.072
   User                                  137 (27.3)   1.96         43.8                   
   Nonuser                               365 (72.7)   1.91         35.1                   
  Currently in methadone program                                                          0.206
   Yes                                   175 (34.9)   1.90         33.7                   
   No                                    327 (65.1)   1.94         39.5                   
  Problem drinking (any CAGE symptoms)                                                    0.087
   Yes                                   269 (53.6)   1.94         40.9                   
   No                                    233 (46.4)   1.90         33.5                   
  Current cigarette smoker                                                                0.549
   Smoker                                339 (67.5)   1.92         38.4                   
   Nonsmoker                             163 (32.5)   1.93         35.6                   

**Note:** Chi-squared.

**Abbreviations:** CES-D, Center for Epidemiologic Studies Short Depression Scale.

###### 

Multiple logistic regression: Independent predictors of positive attitude toward menopause

  Variable                                                  Adjusted odds ratio   95% confidence interval   p-value
  --------------------------------------------------------- --------------------- ------------------------- -----------
  Race/ethnicity                                                                                            
   African American                                         1.718                 1.156--2.566              0.007
   White                                                    1.353                 0.685--2.670              0.384
   Hispanic                                                                                                 Reference
   Death events[\*](#tfn3-cia-3-561){ref-type="table-fn"}   0.635                 0.432--0.933              0.021
   Menopause                                                                                                
   Symptoms \>3                                             0.622                 0.418--0.925              0.019

**Note:** Death of a child or witness to murder.
